Profiel
Mark Levick served as Global Head-Development at Sandoz Biopharmaceuticals from 2016 to 2019.
Dr. Levick was Chief Executive Officer at Alvotech from 2019 to 2023.
Dr. Levick was Chief Executive Officer & Director at InterAx Biotech AG from 2023 to 2025.
Dr. Levick was Chief Executive Officer at Alvotech hf.
Dr. Levick was Global Head at Novartis AG.
Dr. Levick earned a doctorate from the University of Cambridge and completed undergraduate studies at The University of Newcastle.
Eerdere bekende functies van Mark Levick
| Bedrijven | Functie | Einde |
|---|---|---|
InterAx Biotech AG
InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops a platform for discovery of functionally selective drugs | Algemeen Directeur | 17-10-2025 |
| ALVOTECH | Algemeen Directeur | 01-01-2023 |
Sandoz Biopharmaceuticals | Corporate Officer/Principal | 01-01-2019 |
| NOVARTIS AG | Corporate Officer/Principal | 01-07-2016 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Algemeen Directeur | - |
Opleiding van Mark Levick
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Newcastle
The University of Newcastle Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
InterAx Biotech AG
InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops a platform for discovery of functionally selective drugs | Commercial Services |
Alvotech
Alvotech BiotechnologyHealth Technology Develops biologic medicines | Health Technology |
Sandoz Biopharmaceuticals |
















